First Financial Corp Abb Vie Inc. Transaction History

First Financial Corp

$196 Million
Q1 2024

A detailed history of First Financial Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, First Financial Corp holds 11,078 shares of ABBV stock, worth $1.82 Million. This represents 1.03% of its overall portfolio holdings.

Number of Shares

11,078

Previous 16,255 31.85%

Holding current value

$1.82 Million

Previous $2.52 Million 19.93%

% of portfolio

1.03%

Previous 1.29%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	SELL	$159.82 - $182.1 $827,388 - $942,731	-5,177 Reduced 31.85%	11,078 $2.02 Million
Q4 2023 Jan 16, 2024	SELL	$137.6 - $154.97 $84,211 - $94,841	-612 Reduced 3.63%	16,255 $2.52 Million
Q3 2023 Oct 11, 2023	BUY	$133.59 - $154.65 $965,454 - $1.12 Million	7,227 Added 74.97%	16,867 $2.51 Million
Q2 2023 Jul 14, 2023	SELL	$132.51 - $164.9 $25,706 - $31,990	-194 Reduced 1.97%	9,640 $1.3 Million
Q1 2023 Apr 17, 2023	SELL	$144.61 - $166.54 $24,005 - $27,645	-166 Reduced 1.66%	9,834 $1.57 Million

Q4 2022 Jan 17, 2023	SELL	$138.31 - $165.87 $2,766 - $3,317	-20 Reduced 0.2%	10,000 $0
Q3 2022 Oct 20, 2022	SELL	$134.21 - $153.93 $9,260 - $10,621	-69 Reduced 0.68%	10,020 $1.35 Million
Q2 2022 Jul 15, 2022	SELL	$137.62 - $174.96 $5,367 - $6,823	-39 Reduced 0.39%	10,089 $1.55 Million
Q1 2022 Apr 14, 2022	SELL	$131.98 - $163.75 $17,817 - $22,106	-135 Reduced 1.32%	10,128 $1.64 Million
Q4 2021 Jan 14, 2022	BUY	$107.43 - $135.93 $5,478 - $6,932	51 Added 0.5%	10,263 $1.39 Million
Q3 2021 Oct 18, 2021	SELL	$106.4 - $120.78 $5,958 - $6,763	-56 Reduced 0.55%	10,212 $1.1 Million
Q2 2021 Jul 15, 2021	BUY	$105.21 - $117.21 $44,924 - $50,048	427 Added 4.34%	10,268 $1.16 Million
Q1 2021 Apr 15, 2021	BUY	$102.3 - $112.62 $7,877 - $8,671	77 Added 0.79%	9,841 $1.07 Million
Q4 2020 Jan 15, 2021	BUY	$80.49 - $108.67 $4,426 - $5,976	55 Added 0.57%	9,764 $1.05 Million
Q3 2020 Oct 13, 2020	SELL	$85.91 - $100.83 $2,577 - $3,024	-30 Reduced 0.31%	9,709 $850,000
Q2 2020 Jul 15, 2020	SELL	$73.37 - $98.18 $9,978 - $13,352	-136 Reduced 1.38%	9,739 $956,000
Q1 2020 Apr 15, 2020	SELL	$64.5 - $97.79 $16,254 - $24,643	-252 Reduced 2.49%	9,875 $752,000
Q3 2019 Oct 15, 2019	SELL	$62.98 - $75.72 $14,926 - $17,945	-237 Reduced 2.29%	10,127 $767,000
Q2 2019 Jul 15, 2019	SELL	$65.7 - $83.98 $10,052 - $12,848	-153 Reduced 1.45%	10,364 $754,000
Q1 2019 Apr 12, 2019	SELL	$77.14 - $90.79 $9,796 - $11,530	-127 Reduced 1.19%	10,517 $847,000
Q4 2018 Jan 15, 2019	SELL	$77.85 - $96.01 $23,043 - $28,418	-296 Reduced 2.71%	10,644 $981,000
Q3 2018 Oct 16, 2018	SELL	$88.91 - $98.84 $12,269 - $13,639	-138 Reduced 1.25%	10,940 $1.04 Million
Q2 2018 Jul 12, 2018	SELL	$89.78 - $106.23 $22,085 - $26,132	-246 Reduced 2.17%	11,078 $1.03 Million
Q1 2018 Apr 17, 2018	SELL	$92.01 - $123.21 $74,436 - $99,676	-809 Reduced 6.67%	11,324 $1.07 Million
Q4 2017 Jan 16, 2018	SELL	$89.56 - $98.21 $135,325 - $148,395	-1,511 Reduced 11.07%	12,133 $1.17 Million
Q3 2017 Oct 13, 2017	BUY	$69.85 - $89.22 $953,033 - $1.22 Million	13,644	13,644 $1.21 Million

Others Institutions Holding ABBV

# of Institutions

3,653

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $290B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Financial Corp , based on Form 13F filings with the SEC.

News

Stay updated on First Financial Corp with notifications on news.

Account

First Financial Corp Abb Vie Inc. Transaction History